Loading company…
PureVision develops glaucoma treatment stents and other ophthalmic medical devices.
Founded in 2020 and based in Guangzhou, China, PureVision is the trading name of Guangzhou Langmu Life Technology Co., Ltd., a medical technology company developing glaucoma treatment stents. Its AqueFish™ stent is designed for closed-angle and open-angle glaucoma. In December 2025, it raised approximately CNY 100 million in Series A funding co-led by Guangzhou Industry Investment Holding Group and Guangdong Technology Financial Group, with Honde Capital, Guangzhou Development District City Development Fund, Wanlian Jianzhi, and Guangzhou Guoju Venture Capital also participating. The funding is intended for clinical follow-up, product registration, production, marketing, and research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in